LWMI
NVO

Legacy Wealth Management (Idaho)’s Novo Nordisk NVO Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$662 – 694
2026
Q1 		$662 Sell
18
-99
-85% -$4.69K ﹤0.01% 918
2025
Q4 		$5.95K Buy
117
+8
+7% +$409 ﹤0.01% 508
2025
Q3 		$6.05K Hold
109
– – ﹤0.01% 407
2025
Q2 		$7.52K Hold
109
– – ﹤0.01% 351
2025
Q1 		$7.57K Hold
109
– – 0.01% 377
2024
Q4 		$9.42K Hold
109
– – 0.01% 297
2024
Q3 		$11.7K Buy
+109
New +$14.5K 0.01% 288

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s NVO Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 18 shares — an estimated $662 sold.

Legacy Wealth Management (Idaho) first reported a position in NVO in Q3 2024 and held it in 7 quarters. The position peaked at $11.7K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 18 Novo Nordisk shares in Q2 2026, an estimated $662.
  • Legacy Wealth Management (Idaho) first reported a position in Novo Nordisk in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Novo Nordisk position peaked at $11.7K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.